Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models

Journal of Cellular Biochemistry

Volumn 107, Issue 4, 2009, Pages 592-599

  Freund, Christian ^a   Mummery, Christine L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiomyocyte; Disease model; Human embryonic stem cell; Induced pluripotent stem cell; Transplantation

Indexed keywords

CELL DIFFERENTIATION; CELL THERAPY; DISEASE MODEL; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; HEART MUSCLE CELL; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL TRANSPLANTATION; HEART DISEASES; HUMANS; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS;

IPS;

EID: 67650034307     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22164     Document Type: Review

References (50)

1. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bilic J, Pekarik V, Tiscornia G, Edel M, Boue S, Belmonte JC. 2008. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26:1276-1284.
2. Ahuja P, Sdek P, MacLellan WR. 2007. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev 87:521-544. (Pubitemid 47086282)
3. Anderson D, Self T, Mellor IR, Goh G, Hill SJ, Denning C. 2007. Transgenic enrichment of cardiomyocytes from human embryonic stem cells. Mol Ther 15:2027-2036. (Pubitemid 350011743)
4. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, Chiba T, Yamanaka S. 2008. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321:699-702.
5. Bourajjaj M, Armand AS, da Costa Martins PA, Weijts B, van der NR, Heeneman S, Wehrens XH, De Windt LJ. 2008. NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure. J Biol Chem 283:22295-22303.
6. Boyer LA, Mathur D, Jaenisch R. 2006. Molecular control of pluripotency. Curr Opin Genet Dev 16:455-462.
7. Braam S, Denning C, Matsa E, Young L, Passier R, Mummery C. 2008. Feederfree culture of human embryonic stem cells in conditioned medium for efficient genetic modification. Nat Protoc 3:1435-1443.
8. Brand T. 2003. Heart development: Molecular insights into cardiac specifi- cation and early morphogenesis. Dev Biol 258:1-19. (Pubitemid 36637027)
9. Caspi O, Huber I, Kehat I, Habib M, Arbel G, Gepstein A, Yankelson L, Aronson D, Beyar R, Gepstein L. 2007. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 50:1884-1893. (Pubitemid 350007960)
10. Charpentier F, Bourge A, Merot J. 2008. Mouse models of SCN5A-related cardiac arrhythmias. Prog Biophys Mol Biol 98(2-3): 230-237.
11. Ebert AD, Yu J, Rose FF, Jr., Mattis VB, Lorson CL, Thomson JA, Svendsen CN. 2009. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457:277-280.
12. Erdo F, Buhrle C, Blunk J, Hoehn M, Xia Y, Fleischmann B, Focking M, Kustermann E, Kolossov E, Hescheler J, Hossmann KA, Trapp T. 2003. Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab 23:780-785. (Pubitemid 36818686)
13. Evans MJ, Kaufman MH. 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-156. (Pubitemid 11050741)
14. Freund C, Ward-Van Oostwaard D, Monshouwer-Kloots J, van den Brink S, Van Rooijen M, Xu X, Zweigerdt R, Mummery C, Passier R. 2007. Insulin redirects differentiation from cardiogenic mesoderm and endoderm to neuroectoderm in differentiating human embryonic stem cells. Stem Cells 26:724-733.
15. Giudice A, Trounson A. 2008. Genetic modification of human embryonic stem cells for derivation of target cells. Cell Stem Cell 2:422-433. (Pubitemid 351598085)
16. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, Beard C, Brambrink T, Wu LC, Townes TM, Jaenisch R. 2007. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318:1920-1923.
17. Kehat I. 2001. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108:407-414. (Pubitemid 32730787)
18. Kim JB, Sebastiano V, Wu G, Rauzo-Bravo MJ, Sasse P, Gentile L, Ko K, Ruau D, Ehrich M, van den BD, Meyer J, Hubner K, Bernemann C, Ortmeier C, Zenke M, Fleischmann BK, Zaehres H, Scholer HR. 2009. Oct4-induced pluripotency in adult neural stem cells. Cell 136:411-419.
19. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE. 2007. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25:1015-1024. (Pubitemid 47517637)
20. Martin GR. 1981. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78:7634-7638. (Pubitemid 12186197)
21. Martin-Puig S, Wang Z, Chien KR. 2008. Lives of a heart cell: Tracing the origins of cardiac progenitors. Cell Stem Cell 2:320-331.
22. Mummery C, Ward-Van Oostwaard D, Doevendans P, Spijker R, van den Brink S, Hassink R, van der Heyden M, Opthof T, Pera M, de la Riviere AB, Passier R, Tertoolen L. 2003. Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells. Circulation 107:2733-2740. (Pubitemid 36667249)
23. Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, Matsuoka S, Yamanaka S, Yamashita JK. 2008. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118:498-506.
24. Nascone N, Mercola M. 1995. An inductive role for the endoderm in Xenopus cardiogenesis. Development 121:515-523.
25. Ng RK, Gurdon JB. 2008. Epigenetic memory of an active gene state depends on histone H3.3 incorporation into chromatin in the absence of transcription. Nat Cell Biol 10:102-109.
26. Ng ES, Davis RP, Azzola L, Stanley EG, Elefanty AG. 2005. Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation. Blood 106:1601-1603. (Pubitemid 41208571)
27. Ng ES, Davis R, Stanley EG, Elefanty AG. 2008. A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies. Nat Protoc 3:768-776. (Pubitemid 351639021)
28. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. 2008. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949-953.
29. Osafune K, Caron L, Borowiak M, Martinez RJ, Fitz-Gerald CS, Sato Y, Cowan CA, Chien KR, Melton DA. 2008. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol 26:313-315. (Pubitemid 351355125)
30. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ. 2008. Disease-specific induced pluripotent stem cells. Cell 134:877-886.
31. Passier R, Oostwaard DW, Snapper J, Kloots J, Hassink RJ, Kuijk E, Roelen B, de la Riviere AB, Mummery C. 2005. Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells 23:772-780. (Pubitemid 40791792)
32. Remme CA, Wilde AA, Bezzina CR. 2008. Cardiac sodium channel overlap syndromes: Different faces of SCN5A mutations. Trends Cardiovasc Med 18:78-87. (Pubitemid 351626603)
33. Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR, Ding S. 2008. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3:568-574.
34. Smits AM, van VP, Metz CH, Korfage T, Sluijter JP, Doevendans PA, Goumans MJ. 2009. Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: An in vitro model for studying human cardiac physiology and pathophysiology. Nat Protoc 4:232-243.
35. Soor GS, Luk A, Ahn E, Abraham JR, Woo A, Ralph-Edwards A, Butany J. 2009. Hypertrophic cardiomyopathy: Current understanding and treatment objectives. J Clin Pathol 62:226-235.
36. Spits C, Mateizel I, Geens M, Mertzanidou A, Staessen C, Vandeskelde Y, Van der EJ, Liebaers I, Sermon K. 2008. Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnol 26:1361-1363.
37. Stadtfeld M, Brennand K, Hochedlinger K. 2008a. Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol 18:890-894.
38. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. 2008b. Induced pluripotent stem cells generated without viral integration. Science 322:945-949.
39. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676. (Pubitemid 44233629)
40. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872. (Pubitemid 350138099)
41. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147. (Pubitemid 28516247)
42. Tomescot A, Leschik J, Bellamy V, Dubois G, Messas E, Bruneval P, Desnos M, Hagege AA, Amit M, Itskovitz J, Menasche P, Puceat M. 2007. Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats. Stem Cells 25:2200-2205. (Pubitemid 47480478)
43. van Laake LW, Passier R, Monshouwer-Kloots J, Verkleij AJ, Lips DJ, Freund C, den Ouden K, Ward-van Oostwaard D, Korving J, Tertoolen LG, van Echteld CJ, Doevendans PA, Mummery CL. 2007. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res 1:9-24. (Pubitemid 350251944)
44. van Laake LW, Passier R, Doevendans PA, Mummery CL. 2008. Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res 102:1008-1010. (Pubitemid 351667854)
45. Xie H, Ye M, Feng R, Graf T. 2004. Stepwise reprogramming of B cells into macrophages. Cell 117:663-676.
46. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, Kennedy M, Henckaerts E, Bonham K, Abbott GW, Linden RM, Field LJ, Keller GM. 2008. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453:524-528. (Pubitemid 351733312)
47. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
48. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA, Kamp TJ. 2009. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104:e30-e41.
49. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. 2008. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455:627-632.
50. Zimmermann WH. 2009. Remuscularizing failing hearts with tissue engineered myocardium. Antioxid Redox Signal [Epub ahead of print].